251 related articles for article (PubMed ID: 22523431)
21. Resistin-like molecule-beta in scleroderma-associated pulmonary hypertension.
Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Teng X; Hassoun PM; Yang SC; Champion HC; Tuder RM; Johns RA
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):553-61. PubMed ID: 19251945
[TBL] [Abstract][Full Text] [Related]
22. T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis.
Boleto G; Guignabert C; Pezet S; Cauvet A; Sadoine J; Tu L; Nicco C; Gobeaux C; Batteux F; Allanore Y; Avouac J
Arthritis Res Ther; 2018 Aug; 20(1):197. PubMed ID: 30157927
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of
Schniering J; Guo L; Brunner M; Schibli R; Ye S; Distler O; Béhé M; Maurer B
Arthritis Res Ther; 2018 Aug; 20(1):183. PubMed ID: 30115119
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.
Bagnato G; Bitto A; Pizzino G; Irrera N; Sangari D; Cinquegrani M; Roberts WN; Matucci Cerinic M; Squadrito F; Altavilla D; Bagnato G; Saitta A
Rheumatology (Oxford); 2013 Aug; 52(8):1377-86. PubMed ID: 23620550
[TBL] [Abstract][Full Text] [Related]
25. Latent pulmonary inflammation in patients with systemic sclerosis.
Sánchez-Vidaurre S; Simeón CP; Cruz MJ; Fonollosa V; Vilardell M; Morell F; Muñoz X
Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.
Cauvet A; Decellas A; Guignabert C; Rongvaux-Gaïda D; Thuillet R; Ottaviani M; Tu L; Rieger F; Avouac J; Allanore Y
Arthritis Res Ther; 2023 Sep; 25(1):167. PubMed ID: 37700377
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
[TBL] [Abstract][Full Text] [Related]
28. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.
Bahi M; Li C; Wang G; Korman BD
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731946
[TBL] [Abstract][Full Text] [Related]
29. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA
Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508
[TBL] [Abstract][Full Text] [Related]
30. The pulmonary pathologic manifestations of the CREST syndrome.
Yousem SA
Hum Pathol; 1990 May; 21(5):467-74. PubMed ID: 2186993
[TBL] [Abstract][Full Text] [Related]
31. Emerging drugs and therapeutics for systemic sclerosis.
Lee JJ; Pope JE
Expert Opin Emerg Drugs; 2016 Dec; 21(4):421-430. PubMed ID: 27813423
[TBL] [Abstract][Full Text] [Related]
32. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1.
Eferl R; Hasselblatt P; Rath M; Popper H; Zenz R; Komnenovic V; Idarraga MH; Kenner L; Wagner EF
Proc Natl Acad Sci U S A; 2008 Jul; 105(30):10525-30. PubMed ID: 18641127
[TBL] [Abstract][Full Text] [Related]
33. Animal models of scleroderma: fresh insights.
Artlett CM
Curr Opin Rheumatol; 2010 Nov; 22(6):677-82. PubMed ID: 20720495
[TBL] [Abstract][Full Text] [Related]
34. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
35. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
36. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene.
Said SI; Hamidi SA; Dickman KG; Szema AM; Lyubsky S; Lin RZ; Jiang YP; Chen JJ; Waschek JA; Kort S
Circulation; 2007 Mar; 115(10):1260-8. PubMed ID: 17309917
[TBL] [Abstract][Full Text] [Related]
37. Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis.
Frantz C; Cauvet A; Durand A; Gonzalez V; Pierre R; Do Cruzeiro M; Bailly K; Andrieu M; Orvain C; Avouac J; Ottaviani M; Thuillet R; Tu L; Guignabert C; Lucas B; Auffray C; Allanore Y
Arthritis Rheumatol; 2022 Aug; 74(8):1387-1398. PubMed ID: 35255201
[TBL] [Abstract][Full Text] [Related]
38. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary arterial hypertension in systemic sclerosis.
Lambova S; Müller-Ladner U
Autoimmun Rev; 2010 Sep; 9(11):761-70. PubMed ID: 20601197
[TBL] [Abstract][Full Text] [Related]
40. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?
Jimenez SA; Piera-Velazquez S
Matrix Biol; 2016 Apr; 51():26-36. PubMed ID: 26807760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
